Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,439 | 47,712 | 37,340 | 33,785 | 54,039 |
| Marketable Securities | 145,070 | 154,899 | 25,291 | 35,711 | 35,337 |
| Receivables | 16,841 | 18,266 | 12,617 | 10,509 | 7,790 |
| Inventories | 1,367 | 1,108 | 2,559 | 1,970 | N/A |
| TOTAL | $225,115 | $226,337 | $81,573 | $86,027 | $99,442 |
| Non-Current Assets | |||||
| PPE Net | 488 | 599 | 422 | 356 | 607 |
| Investments And Advances | 30,865 | 15,089 | 6,091 | 6,010 | 6,105 |
| Intangibles | 11,438 | 11,754 | 72,078 | 73,694 | 75,309 |
| Other Non-Current Assets | 2,210 | 2,498 | 12,544 | 12,040 | 10,088 |
| TOTAL | $45,001 | $29,940 | $91,135 | $92,100 | $92,109 |
| Total Assets | $270,116 | $256,277 | $172,708 | $178,127 | $191,551 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,072 | 15,842 | 17,819 | 25,456 | 24,464 |
| Other current liabilities | 14,599 | 12,465 | 8,568 | 8,189 | 9,477 |
| TOTAL | $26,112 | $28,832 | $26,976 | $34,065 | $34,481 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,310 | 60,692 | 60,090 | 59,504 | 58,904 |
| Other Non-Current Liabilities | 49,529 | 49,523 | 44,619 | 44,892 | 28,396 |
| TOTAL | $110,839 | $110,215 | $104,709 | $104,396 | $87,300 |
| Total Liabilities | $136,951 | $139,047 | $131,685 | $138,461 | $121,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,298 | 56,135 | 54,680 | 54,116 | 53,376 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -434,225 | -433,681 | -508,388 | -505,289 | -469,550 |
| Other shareholders' equity | -2,399 | -2,411 | -65 | 648 | -98 |
| TOTAL | $133,165 | $117,230 | $41,023 | $39,666 | $69,770 |
| Total Liabilities And Equity | $270,116 | $256,277 | $172,708 | $178,127 | $191,551 |